Tyra Biosciences Inc (TYRA) — Financial Flexibility Index
Tyra Biosciences Inc (TYRA) has a Financial Flexibility Index of -1.01x as of December 2025. Free cash flow of $-23.57 Million (operating CF $-23.62 Million minus capex $57.00K) represents -1% of total liabilities ($23.43 Million). Also explore Tyra Biosciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tyra Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Tyra Biosciences Inc across 7 annual periods. Check Tyra Biosciences Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Tyra Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Tyra Biosciences Inc. For the full company profile including market capitalisation, see TYRA stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.05x | $-95.00 Million | $-95.14 Million | $23.43 Million | ▼ -19.7% |
| 2024 | -3.39x | $-69.11 Million | $-69.77 Million | $20.41 Million | ▼ -48.1% |
| 2023 | -2.29x | $-49.37 Million | $-50.14 Million | $21.59 Million | ▲ +61.6% |
| 2022 | -5.95x | $-49.73 Million | $-50.28 Million | $8.35 Million | ▼ -28.0% |
| 2021 | -4.65x | $-23.08 Million | $-23.75 Million | $4.96 Million | ▼ -1750.4% |
| 2020 | -0.25x | $-7.45 Million | $-7.76 Million | $29.65 Million | ▲ +49.0% |
| 2019 | -0.49x | $-2.60 Million | $-2.62 Million | $5.27 Million | — |